Tone mix
Week by week 52 weeks
Share of Protagonist Therapeutics, Inc's 151 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Aug 11, 2025 · tone +100Protagonist Therapeutics (NASDAQ:PTGX) Price Target Raised to $69.00+100
- Week of Nov 24, 2025 · tone -50Protagonist Therapeutics: Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice-74
- Week of Mar 2, 2026 · tone +100The Goldman Sachs Group Issues Positive Forecast for Protagonist Therapeutics (NASDAQ:PTGX) Stock Price+68
- Week of Sep 22, 2025 · tone +100Protagonist Therapeutics' (PTGX) "Buy" Rating Reiterated at HC Wainwright+61
- Week of Apr 21, 2025 · tone 0Protagonist Therapeutics Announces Plenary Presentation on VERIFY Phase 3 Study with Rusfertide at A-60
- Week of Jan 5, 2026 · tone +76Analysts Set Protagonist Therapeutics, Inc. (NASDAQ:PTGX) PT at $85.08+54
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Protagonist Therapeutics, Inc in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 3 | 0 |
| Last 30 sessions | 8 | -11 |
| Last 90 sessions | 36 | +32 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Tuesday, October 27, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.tennesseedaily.com · 2 outletsProtagonist Therapeutics to Participate in Four Investment Bank Conferences in November 2026Neutral
- www.pr-inside.com · 1 outletProtagonist Therapeutics to Participate in Four Investment Bank Conferences ...Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Protagonist Therapeutics to Participate in Four Investment Bank Conferences in November 2026 | www.tennesseedaily.com | 2 | Neutral |
| Protagonist Therapeutics to Participate in Four Investment Bank Conferences ... | www.pr-inside.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 22, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletComparing Sarepta Therapeutics (NASDAQ:SRPT) and Protagonist Therapeutics (NASDAQ:PTGX)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Comparing Sarepta Therapeutics (NASDAQ:SRPT) and Protagonist Therapeutics (NASDAQ:PTGX) | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 14, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletProtagonist Therapeutics (NASDAQ:PTGX) Stock Rating Upgraded by UBS GroupPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Protagonist Therapeutics (NASDAQ:PTGX) Stock Rating Upgraded by UBS Group | www.themarketsdaily.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 13, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletComparing Protagonist Therapeutics (NASDAQ:PTGX) and Genelux (NASDAQ:GNLX)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Comparing Protagonist Therapeutics (NASDAQ:PTGX) and Genelux (NASDAQ:GNLX) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 12, 2026
2 headlines, average tone -93: 0 positive, 0 neutral and 2 negative. Showing all 2.
- www.themarketsdaily.com · 1 outletProtagonist Therapeutics (NASDAQ:PTGX) Stock Gets Downgrade from Wall Street ZenNegative
- www.dailypolitical.com · 1 outletProtagonist Therapeutics (NASDAQ:PTGX) Downgraded by Wall Street Zen to BuyNegative
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Protagonist Therapeutics (NASDAQ:PTGX) Stock Gets Downgrade from Wall Street Zen | www.themarketsdaily.com | 1 | Negative |
| Protagonist Therapeutics (NASDAQ:PTGX) Downgraded by Wall Street Zen to Buy | www.dailypolitical.com | 1 | Negative |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Protagonist Therapeutics, Inc, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.